Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Is Wall Street Bullish or Bearish on DexCom Stock?

With a market cap of $34.5 billion, DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes continuous glucose monitoring (CGM) systems for diabetes and metabolic health management in the United States and internationally. It offers products such as Dexcom G6, Dexcom G7, Dexcom ONE, and Stelo, serving patients, caregivers, and clinicians worldwide.

Shares of the medical device company have underperformed the broader market over the past 52 weeks. DXCM stock has increased 13.8% over this time frame, while the broader S&P 500 Index ($SPX) has returned 20.3%. However, the stock has soared 37.2% on a YTD basis, outpacing SPX's 13.7% gain.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.